Weight-Loss drug liraglutide tested in kids as young as 6
NCT ID NCT07590219
First seen May 16, 2026 · Last updated Jun 19, 2026 · Updated 9 times
Summary
This study tests whether the drug liraglutide, combined with healthy lifestyle changes, can help children aged 6 to 12 with severe obesity lose weight and improve heart function. Thirty children will receive either liraglutide injections plus lifestyle advice or lifestyle advice alone for 6 months. Researchers will measure changes in body mass index (BMI) and use advanced heart ultrasound to check for cardiovascular benefits.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHILDHOOD OBESITY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Childrens Institute - University of Sao Paulo
São Paulo, São Paulo, 05403-000, Brazil
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
liraglutide (Saxenda)
What this could lead to
If it works, this could point toward a medication option to help severely obese children lose weight and improve heart health.
What could go wrong
This is a small, early-phase trial with only 30 children, so results may not apply broadly. Liraglutide can cause nausea, vomiting, and other side effects.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.